Compare MPTI & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MPTI | ETON |
|---|---|---|
| Founded | 1965 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 327.9M | 1.3B |
| IPO Year | 2022 | 2018 |
| Metric | MPTI | ETON |
|---|---|---|
| Price | $76.96 | $51.98 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $83.00 | $71.00 |
| AVG Volume (30 Days) | 54.8K | ★ 361.4K |
| Earning Date | 11-11-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.07 | 0.41 |
| Revenue | $54,417,000.00 | ★ $79,950,000.00 |
| Revenue This Year | $11.45 | $88.01 |
| Revenue Next Year | $12.37 | $49.11 |
| P/E Ratio | ★ $71.88 | $143.90 |
| Revenue Growth | 11.03 | ★ 104.94 |
| 52 Week Low | $43.55 | $14.27 |
| 52 Week High | $104.85 | $66.37 |
| Indicator | MPTI | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 53.00 | 40.27 |
| Support Level | $72.03 | $40.61 |
| Resistance Level | $80.42 | $66.37 |
| Average True Range (ATR) | 2.45 | 3.32 |
| MACD | 0.64 | -0.85 |
| Stochastic Oscillator | 80.39 | 23.54 |
M-Tron Industries Inc is an electronic components manufacturer based in the United States. Along with its subsidiaries, the company is engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company serves markets in aerospace and defense, space, and avionics sectors. Its product offerings include microwave and millimeter-wave filters, crystal resonators, clock oscillators, voltage-controlled crystal oscillators, low noise amplifiers, couplers, attenuators, and switches, among others. Geographically, it derives maximum revenue from the domestic market, and the rest from Malaysia, Australia, Greece, and other countries.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.